AI Science Tracker

AlphaMissense: cataloging missense genetic mutations

Google DeepMind · 19 Sep 2023 · biology

Discovery

Google DeepMind

AlphaMissense: cataloging missense genetic mutations

It classified 89% of the 71 million possible missense variants: 32% as likely pathogenic and 57% as likely benign, with 90% precision on a database of known variants. Predictions are not intended for direct clinical use.

Technology: AlphaMissense

Family AlphaMissense: profile · models page

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: The model was validated on genetic and experimental benchmarks, and Genomics England cross-referenced its predictions with previously aggregated human variant pathogenicity data and found them consistent. The reported comparison uses previously collected pathogenicity and variant data; an independent data source is distinct from a new independent experimental replication.
  • Still unknown: The model does not predict structural or stability effects, the blog says predictions are not designed for direct clinical use, and the abstract describes no clinical validation.
  • AI role: AlphaMissense, an AlphaFold adaptation fine-tuned on human and primate variant population frequency data, classified missense variants and released predictions for all possible human substitutions.

Evidence sources: https://deepmind.google/blog/a-catalogue-of-genetic-mutations-to-help-pinpoint-the-cause-of-diseases/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1126/science.adg7492&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: blog. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 2381 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.